Singapore Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
Singapore Pharmaceuticals Market @Summary, Competitive Analysis and Forecast to 2026
SUMMARY
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Singaporean pharmaceuticals market had total revenues of $1.3 billion in 2021, representing a compound annual growth rate (CAGR) of 5.9% between 2016 and 2021.
- Singaporean healthcare is one of the best in the world in terms of both efficiency and health outcome results and government healthcare expenditure has also been steadily on the rise, conditions which have been strongly conducive to market growth.
- The Singaporean government has invested aggressively in its biomedical industry over the last few years, encouraging the top companies to set up manufacturing units and R&D centers in the country.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Singapore pharmaceuticals market by value in 2021?
- What will be the size of the Singapore pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Singapore’s pharmaceuticals market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. What trends have impacted the market?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Pfizer Inc.
8.3. Astellas Pharma Inc.
8.4. GSK plc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. What trends have impacted the market?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Pfizer Inc.
8.3. Astellas Pharma Inc.
8.4. GSK plc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Singapore pharmaceuticals market value: $ billion, 2016–21
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Singapore pharmaceuticals market share: % share, by value, 2021
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Astellas Pharma Inc.: key facts
Table 14: Astellas Pharma Inc.: Annual Financial Ratios
Table 15: Astellas Pharma Inc.: Key Employees
Table 16: GSK plc.: key facts
Table 17: GSK plc.: Annual Financial Ratios
Table 18: GSK plc.: Key Employees
Table 19: GSK plc.: Key Employees Continued
Table 20: Singapore size of population (million), 2017–21
Table 21: Singapore gdp (constant 2005 prices, $ billion), 2017–21
Table 22: Singapore gdp (current prices, $ billion), 2017–21
Table 23: Singapore inflation, 2017–21
Table 24: Singapore consumer price index (absolute), 2017–21
Table 25: Singapore exchange rate, 2017–21
Table 1: Singapore pharmaceuticals market value: $ billion, 2016–21
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Singapore pharmaceuticals market share: % share, by value, 2021
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Astellas Pharma Inc.: key facts
Table 14: Astellas Pharma Inc.: Annual Financial Ratios
Table 15: Astellas Pharma Inc.: Key Employees
Table 16: GSK plc.: key facts
Table 17: GSK plc.: Annual Financial Ratios
Table 18: GSK plc.: Key Employees
Table 19: GSK plc.: Key Employees Continued
Table 20: Singapore size of population (million), 2017–21
Table 21: Singapore gdp (constant 2005 prices, $ billion), 2017–21
Table 22: Singapore gdp (current prices, $ billion), 2017–21
Table 23: Singapore inflation, 2017–21
Table 24: Singapore consumer price index (absolute), 2017–21
Table 25: Singapore exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Singapore pharmaceuticals market value: $ billion, 2016–21
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2021
Figure 10: Singapore pharmaceuticals market share: % share, by value, 2021
Figure 1: Singapore pharmaceuticals market value: $ billion, 2016–21
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2021
Figure 10: Singapore pharmaceuticals market share: % share, by value, 2021
